Delta-Fly Pharmaの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/07 | 1,220 | 1,291 | 1,166 | 1,173 | -40 | -3.3% | 126,400 |
2021/01/06 | 1,163 | 1,221 | 1,162 | 1,213 | +45 | +3.9% | 85,000 |
2021/01/05 | 1,174 | 1,186 | 1,148 | 1,168 | -12 | -1% | 62,600 |
2021/01/04 | 1,194 | 1,208 | 1,132 | 1,180 | -15 | -1.3% | 94,300 |
2020/12/30 | 1,182 | 1,214 | 1,178 | 1,195 | ±0 | ±0% | 44,600 |
2020/12/29 | 1,153 | 1,238 | 1,153 | 1,195 | +56 | +4.9% | 96,900 |
2020/12/28 | 1,229 | 1,230 | 1,132 | 1,139 | -46 | -3.9% | 100,100 |
2020/12/25 | 1,210 | 1,253 | 1,185 | 1,185 | -17 | -1.4% | 76,600 |
2020/12/24 | 1,181 | 1,215 | 1,155 | 1,202 | +32 | +2.7% | 73,000 |
2020/12/23 | 1,150 | 1,184 | 1,143 | 1,170 | +48 | +4.3% | 74,900 |
2020/12/22 | 1,183 | 1,183 | 1,120 | 1,122 | -61 | -5.2% | 92,800 |
2020/12/21 | 1,213 | 1,247 | 1,182 | 1,183 | -5 | -0.4% | 78,500 |
2020/12/18 | 1,181 | 1,209 | 1,169 | 1,188 | -11 | -0.9% | 83,200 |
2020/12/17 | 1,192 | 1,251 | 1,190 | 1,199 | +10 | +0.8% | 86,800 |
2020/12/16 | 1,205 | 1,225 | 1,182 | 1,189 | -27 | -2.2% | 95,700 |
2020/12/15 | 1,232 | 1,251 | 1,193 | 1,216 | -46 | -3.6% | 124,500 |
2020/12/14 | 1,224 | 1,262 | 1,200 | 1,262 | -13 | -1% | 197,500 |
2020/12/11 | 1,160 | 1,285 | 1,153 | 1,275 | +102 | +8.7% | 354,000 |
2020/12/10 | 1,244 | 1,265 | 1,155 | 1,173 | -71 | -5.7% | 294,500 |
2020/12/09 | 1,350 | 1,360 | 1,216 | 1,244 | -277 | -18.2% | 653,100 |
2020/12/08 | 1,501 | 1,549 | 1,433 | 1,521 | -32 | -2.1% | 189,000 |
2020/12/07 | 1,657 | 1,661 | 1,538 | 1,553 | -100 | -6% | 143,700 |
2020/12/04 | 1,717 | 1,730 | 1,622 | 1,653 | -64 | -3.7% | 127,000 |
2020/12/03 | 1,738 | 1,795 | 1,711 | 1,717 | -30 | -1.7% | 127,700 |
2020/12/02 | 1,660 | 1,760 | 1,660 | 1,747 | +49 | +2.9% | 158,800 |
2020/12/01 | 1,637 | 1,706 | 1,600 | 1,698 | +39 | +2.4% | 184,200 |
2020/11/30 | 1,720 | 1,760 | 1,650 | 1,659 | -66 | -3.8% | 211,800 |
2020/11/27 | 1,622 | 1,742 | 1,622 | 1,725 | +100 | +6.2% | 152,800 |
2020/11/26 | 1,596 | 1,658 | 1,590 | 1,625 | +29 | +1.8% | 134,700 |
2020/11/25 | 1,654 | 1,663 | 1,572 | 1,596 | -67 | -4% | 297,400 |
2020/11/24 | 1,690 | 1,718 | 1,606 | 1,663 | -29 | -1.7% | 315,200 |
2020/11/20 | 1,692 | 1,700 | 1,621 | 1,692 | -26 | -1.5% | 307,300 |
2020/11/19 | 1,794 | 1,809 | 1,701 | 1,718 | -52 | -2.9% | 271,000 |
2020/11/18 | 1,886 | 1,926 | 1,737 | 1,770 | -104 | -5.5% | 404,900 |
2020/11/17 | 2,077 | 2,090 | 1,872 | 1,874 | -221 | -10.5% | 278,600 |
2020/11/16 | 2,144 | 2,144 | 2,012 | 2,095 | -11 | -0.5% | 116,900 |
2020/11/13 | 1,999 | 2,217 | 1,919 | 2,106 | -45 | -2.1% | 361,100 |
2020/11/12 | 2,200 | 2,221 | 2,127 | 2,151 | -49 | -2.2% | 83,600 |
2020/11/11 | 2,170 | 2,200 | 2,083 | 2,200 | +71 | +3.3% | 104,200 |
2020/11/10 | 2,122 | 2,213 | 2,090 | 2,129 | -11 | -0.5% | 111,500 |
2020/11/09 | 2,130 | 2,149 | 2,041 | 2,140 | +10 | +0.5% | 194,000 |
2020/11/06 | 2,270 | 2,275 | 2,112 | 2,130 | -140 | -6.2% | 195,800 |
2020/11/05 | 2,283 | 2,292 | 2,227 | 2,270 | +28 | +1.2% | 73,500 |
2020/11/04 | 2,173 | 2,256 | 2,162 | 2,242 | +87 | +4% | 118,100 |
2020/11/02 | 2,212 | 2,260 | 2,146 | 2,155 | -78 | -3.5% | 172,100 |
2020/10/30 | 2,360 | 2,383 | 2,230 | 2,233 | -124 | -5.3% | 198,100 |
2020/10/29 | 2,350 | 2,390 | 2,317 | 2,357 | -18 | -0.8% | 161,400 |
2020/10/28 | 2,405 | 2,476 | 2,351 | 2,375 | -47 | -1.9% | 141,300 |
2020/10/27 | 2,351 | 2,469 | 2,331 | 2,422 | -29 | -1.2% | 221,900 |
2020/10/26 | 2,512 | 2,565 | 2,437 | 2,451 | -39 | -1.6% | 263,400 |
951~
1000
件表示中 / 1492件
類似銘柄と比較する
現在ご覧いただいている「DELTA-P」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
DELTA-P | 51,900円 | - | - | 0.00% | - | 14.89倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
キッズバイオ | 12,100円 | - | - | 0.00% | - | 6.37倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞(SHED)用いた再生医療に力 |
ブライトパス | 5,600円 | - | - | 0.00% | - | 3.94倍 |
|
久留米大学発創薬ベンチャー。がん向け遺伝子導入iPS由来細胞医薬や抗体医薬開発に注力 |
免疫生物 | 50,000円 | +13.4% | -4.0% | 0.00% | 40.49倍 | 3.49倍 |
|
研究用試薬の製販・受託。遺伝子組み換えカイコの基礎研究は休止し、化粧品等応用開発に移行 |
ファンペップ | 14,000円 | - | - | 0.00% | - | 2.12倍 |
|
大阪大医研発。患者の体内で抗体の産生を誘導する抗体誘導ペプチドを用いた医薬品を開発 |
市場注目の銘柄
チャート関連のコラム